Skip to Main Content
 

Global Search Box

 
 
 
 

Files

File List


kent1214366273.pdf (2.52 MB)

ETD Abstract Container

Abstract Header

ROLE AND REGULATION OF MYC IN GLIOBLASTOMA MULTIFORME CELL DIFFERENTIATION: IMPLICATION IN TUMOR FORMATION

Mazumdar, Tapati
http://rave.ohiolink.edu/etdc/view?acc_num=kent1214366273

Abstract Details

2008, PHD, Kent State University, College of Arts and Sciences / School of Biomedical Sciences.
Glioblastoma multiforme (GBM) is the most aggressive primary brain cancer in adults. Current treatments prove ineffective in prolonging patient survival beyond 15 months. Molecular characterization of GBM tumors suggest that a minor fraction, called brain tumor stem cells (BTSC), initiate and maintain the tumor; while the majority of cells that resembles differentiated astrocytes are unable to do so. Thus, differentiating the BTSCs may be used as supplementary therapy for GBM. In this regard, a recent study showed that cMyc (hereafter referred to as Myc, in accordance with new nomenclature) expression in differentiated murine astrocytes renders them tumorigenic. Conversely, activated Stat3 is involved in differentiation of murine neural stem cells into astrocytes. However, the mechanisms underlying human GBM cell differentiation are unknown. So we hypothesized that Myc is associated with GBM tumorigenesis, and its interplay with activated Stat3, modulates GBM cell differentiation thereby affecting tumor formation. To test this hypothesis we pursued three specific aims. First, the level of Myc protein was monitored in human GBM cells to determine any correlation between Myc and tumorigenicity of the cells. Secondly, the relationship between Myc and activated Stat3 was explored to determine if a regulatory mechanism exists between these twotranscription factors. Finally, the mechanism of Myc-mediated suppression of glial fibrillary acidic protein (GFAP), a differentiation marker, was investigated. Our results demonstrated that the tumorigenic GBM cell line U87, had higher steady state level of Myc than that in a less tumorigenic GBM cell line, U251. Importantly, activated Stat3 suppressed the steady state level of Myc and thus affected Myc-regulated targets and function in GBM cells. GFAP expression was associated with differentiated astrocytes, and Myc suppresses GFAP expression by an unknown mechanism. Here, we show that Myc inhibited the GFAP promoter activation in human GBM cells. Collectively, these results support our hypothesis that Myc is positively associated with GBM tumorigenicity, and activated Stat3 suppresses Myc protein that inhibits GFAP promoter activation.
Saikh Jaharul Haque, PhD (Advisor)
189 p.
Cellular Biology
GBM; Differentiation; Myc; Stat3; GFAP

Recommended Citations

Citations

  • Mazumdar, T. (2008). ROLE AND REGULATION OF MYC IN GLIOBLASTOMA MULTIFORME CELL DIFFERENTIATION: IMPLICATION IN TUMOR FORMATION [Doctoral dissertation, Kent State University]. OhioLINK Electronic Theses and Dissertations Center. http://rave.ohiolink.edu/etdc/view?acc_num=kent1214366273

    APA Style (7th edition)

  • Mazumdar, Tapati. ROLE AND REGULATION OF MYC IN GLIOBLASTOMA MULTIFORME CELL DIFFERENTIATION: IMPLICATION IN TUMOR FORMATION. 2008. Kent State University, Doctoral dissertation. OhioLINK Electronic Theses and Dissertations Center, http://rave.ohiolink.edu/etdc/view?acc_num=kent1214366273.

    MLA Style (8th edition)

  • Mazumdar, Tapati. "ROLE AND REGULATION OF MYC IN GLIOBLASTOMA MULTIFORME CELL DIFFERENTIATION: IMPLICATION IN TUMOR FORMATION." Doctoral dissertation, Kent State University, 2008. http://rave.ohiolink.edu/etdc/view?acc_num=kent1214366273

    Chicago Manual of Style (17th edition)

kent1214366273
1,134
© 2008, all rights reserved.
This open access ETD is published by Kent State University and OhioLINK.